Icon Wealth Partners’s West Pharmaceutical WST Stock Holding History

Icon Wealth Partners’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$993K	Sell	2,647 -404	-13%	-$156K	0.11%	120
2023 Q2	$1.17M	Sell	3,051 -430	-12%	-$154K	0.12%	123
2023 Q1	$1.21M	Buy	+3,481	New	+$1.02M	0.13%	124
2022 Q2	$1.02M	Sell	3,390 -826	-20%	-$269K	0.12%	132
2022 Q1	$1.73M	Sell	4,216 -1,301	-24%	-$509K	0.17%	106
2021 Q4	$2.59M	Buy	5,517 +26	+0.5%	+$11.2K	0.26%	90
2021 Q3	$2.33M	Buy	5,491 +262	+5%	+$110K	0.25%	97
2021 Q2	$1.88M	Buy	5,229 +629	+14%	+$208K	0.2%	107
2021 Q1	$1.3M	Buy	4,600 +1,030	+29%	+$295K	0.16%	121
2020 Q4	$1.01M	Buy	3,570 +729	+26%	+$205K	0.16%	117
2020 Q3	$781K	Buy	+2,841	New	+$752K	0.15%	112
2019 Q2	–	Sell	-417	Closed	-$46K	–	780
2019 Q1	$46K	Buy	+417	New	+$43.4K	0.02%	372
2018 Q3	–	Sell	-316	Closed	-$31K	–	728
2018 Q2	$31K	Buy	+316	New	+$29.1K	0.01%	490
2018 Q1	–	Sell	-316	Closed	-$31K	–	736
2017 Q4	$31K	Buy	+316	New	+$31K	0.02%	522

Other funds holding WST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Icon Wealth Partners's WST Position: Q3 2023 in Review

Icon Wealth Partners reduced its West Pharmaceutical (WST) stake by 13% in Q3 2023, selling an estimated $156K and leaving 2,647 shares worth $993K. The position accounts for 0.11% of the portfolio, ranked #120.

Icon Wealth Partners first reported a position in WST in Q4 2017 and has held it in 14 quarters since. The position peaked at $2.59M in Q4 2021. 757 funds tracked by Wall St. Rank hold WST as of Q3 2023.

Icon Wealth Partners held 2,647 shares of West Pharmaceutical worth $993K as of Q3 2023.
Icon Wealth Partners sold 404 West Pharmaceutical shares in Q3 2023, an estimated $156K.
West Pharmaceutical made up 0.11% of Icon Wealth Partners's portfolio in Q3 2023, its #120 holding.
Icon Wealth Partners first reported a position in West Pharmaceutical in Q4 2017 and has held it in 14 quarters since.
Icon Wealth Partners's West Pharmaceutical position peaked at $2.59M in Q4 2021.
757 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2023.

Based on Icon Wealth Partners's 13F filing for Q3 2023, filed 14 Nov 2023.